An electrochemical system for the study of trans-plasma membrane electron transport in whole eukaryotic cells by Sherman, Harry G. et al.
  
This document is confidential and is proprietary to the American Chemical Society and its authors. Do not 
copy or disclose without written permission. If you have received this item in error, notify the sender and 
delete all copies. 
 
 
 
An Electrochemical System for the Study of Trans-Plasma 
Membrane Electron Transport in Whole Eukaryotic Cells 
 
 
Journal: Analytical Chemistry 
Manuscript ID ac-2017-048536.R1 
Manuscript Type: Article 
Date Submitted by the Author: 11-Jan-2018 
Complete List of Authors: Sherman, Harry; University of Nottingham, Pharmacy 
Jovanovic, Carolyn; Boots UK Ltd 
Stolnik, Snow; University of Nottingham, Pharmacy 
Rawson, Frankie; University of Nottingham, School of Pharmacy 
  
 
 
ACS Paragon Plus Environment
Analytical Chemistry
 
 
1 
 
An Electrochemical System for the Study of Trans-Plasma 1 
Membrane Electron Transport in Whole Eukaryotic Cells 2 
Harry G. Sherman†, Carolyn Jovanovic‡, Snow Stolnik∞, Frankie J.Rawson†* 3 
†Division of Regenerative Medicine and Cellular Therapies, School of Pharmacy, University of Nottingham, NG7 2RD, UK  4 
∞Division of Molecular Therapeutics and Formulation, School of Pharmacy, University of Nottingham, NG7 2RD, UK                                                     5 
‡ Walgreens Boots Alliance, Nottingham, NG2 3AA, UK 6 
 7 
ABSTRACT: The study of trans-plasma membrane electron transport (tPMET) in oncogenic systems is paramount to the further 8 
understanding of cancer biology. The current literature provides methodology to study these systems that hinges upon mitochondri-9 
al knockout genotypes, or the detection of ferrocyanide using colorimetric methods.  However, when using an iron redox based 10 
system to probe tPMET there is yet to be a method that allows for the simultaneous quantification of iron redox states whilst 11 
providing an exceptional level of sensitivity. Developing a method to simultaneously analyze the redox state of a reporter molecule 12 
would give advantages in probing the underlying biology. Herein we present an electrochemical based method that allows for the 13 
quantification of both ferricyanide and ferrocyanide redox states to a highly sensitive degree. We have applied this system to a nov-14 
el application of assessing oncogenic cell-driven iron reduction, and have shown that it can effectively quantitate and identify dif-15 
ferences in iron reduction capability of three lung epithelial cell lines16 
All cells communicate with their environment via external 17 
electron transfer events. These events are mediated by 18 
(tPMETs) trans-plasma membrane electron transport systems. 19 
The development of new techniques to study cellular electron 20 
transfer via trans plasma membrane electron transport 21 
(tPMET) is required in order to shed light on its role in cellular 22 
homeostasis. The development of new assays for such purpos-23 
es can yield new biological insight regarding their function. 24 
The output of the assays can then be applied for a number of 25 
broad applications, from the development of biosensors1 and 26 
microbial fuel cells2 through to identification of potential new 27 
targets for therapies in which tPMETs are thought to play a 28 
part, such as cancer3. 29 
tPMET plays a fundamental role within mammalian cells by 30 
facilitating the reduction of ferric iron at the duodenal brush 31 
broder4, and detoxifying iron at the environment-exposed lung 32 
epithelium5,6. It is possible to probe these systems using redox 33 
mediators such as potassium ferricyanide (FIC)7, but to date 34 
there has been no application of electrochemistry to simulta-35 
neously quantitate iron redox states in cancer biology. In this 36 
paper we provide an electrochemical based platform for study-37 
ing tPMET through detection of multiple iron redox states to a 38 
highly sensitive degree, and by doing so we identify differ-39 
ences in the reductive capabilities of tPMET in three mamma-40 
lian cancer cell lines. 41 
Iron is an essential micronutrient for all forms of mammalian 42 
life8,9,10,11. Electron transfer across membranes is typically 43 
associated with respiratory electron transport within the mito-44 
chondria, but tPMET also plays a role within a multitude of 45 
processes12 including pH control and signal transduction13, 46 
apoptosis14,15, antioxidation16, and  iron homeostasis13,17,18 .  47 
The tPMET function of the non-transferrin bound iron 48 
transport system is evidenced to be mediated by a NAD(P) 49 
H:oxidoreductase system18, ascorbate shuttle mechanism19, or 50 
ascorbate or AFR-dependant transmembrane reductase sys-51 
tem19. A widely accepted ferrireductase, duodenal cytochrome 52 
b561 (Dcytb), has been shown to be expressed in a wide variety 53 
of cell types including human erythrocytes20, lung epitheli-54 
um21, K562 cells22, astrocytes23, and intestinal origin Caco-2 55 
and HEP-G2 cells24. This is interesting as, apart from in the 56 
gut, ‘free’ non-transferrin bound iron (NTBI) is often unde-57 
tectable, except in cases of iron overload25,26. tPMET systems 58 
may therefore be present as a protective measure if iron over-59 
load does occur, or be present at the plasma membrane of cells 60 
in different tissue throughout the body for a yet unknown 61 
functionality to those identified. This leads to a hypothesis that 62 
the role and upregulation of tPMET in cancer is to reoxidize 63 
cytosolic NADH to allow for continued glycolysis3, in the case 64 
of the Warburg effect27 occurring. Work has been carried out 65 
to look at the presence of tPMET in non-mitochondrial oxygen 66 
consumption, and it has been shown to have involvement not 67 
only in mitochondrial knockout (p0) cells but also for oncogen-68 
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ic cells that possess fully competent mitochondrial activity28.  1 
In light of tPMET mechanisms being present where there may 2 
be yet undiscovered functions, such as in the lung or within 3 
cancer metabolism in relation to NADH3. It is therefore im-4 
perative that we study tPMET in oncology to understand the 5 
underlying biochemistry, as this may lead to better diagnostic 6 
tools and therapeutics. Herein we described the development 7 
of a method that can be used to study tPMET by identifying 8 
different redox states of iron simultaneously. We then have 9 
used this method to identify and differentiate tPMET activity 10 
between cell types of the same tissue and origin – lung epithe-11 
lium, as there has not been any comparison between cancerous 12 
cell lines tPMET activity in this manner.  13 
The techniques used to study components of iron 14 
homeostasis29 can include potentiometry, which has been used 15 
to assess redox properties of duodenal cytochrome b561. Mac-16 
kenzie et al30 have used voltage-clamp experiments in eluci-17 
dating how the divalent metal transporter 1 (DMT1) mediates 18 
both H+-coupled Fe2+ transport in whole oocytes31. Others 19 
have used double electrochemical mediator systems to look at 20 
intracellular redox sites32. Baronian et al33 have also used line-21 
ar sweep voltammetry in the electroanalytical detection of 22 
catabolism in whole cell yeast. McDowall et al34 have used 23 
amperometry to study the lysates of neuroblastoma cells, but 24 
do not investigate whole cell neuroblastoma cells and there-25 
fore they could not assess tPMET. Cancer tPMET (on intact 26 
cells) has been investigated by alternative methods to electro-27 
chemistry. Herst et al3,35, Berridge et al36 and Scarlett et al37 28 
have all used mitochondrial gene-knockout (p0) cells as a way 29 
to study tPMET. Using HL60ρ0 cells they have demonstrated 30 
a link between tPMET and cell surface oxygen consumption, 31 
linked to the Warburg effect27. Avron and Shavit38 previously 32 
developed a colorimetric assay to determine ferrocyanide 33 
(FOC) concentration, which could be used to study tPMET. 34 
This was improved upon by Lane et al7, and used to study 35 
tPMET in a leukaemia cell line. These two colorimetric meth-36 
ods provide sound methodology to study tPMET at a high 37 
throughput level, but as they only quantitate for FOC they lack 38 
ability to quantify both iron redox states present.  In the pre-39 
sent work we develop an electrochemical assay capable of 40 
monitoring and quantifying the redox states of iron to provide 41 
new biological observation on the use of tPMETs in cancer 42 
cell lines.   43 
We have developed an electrochemical assay using linear 44 
sweep voltammetry at a microelectrode, and in a first have 45 
subsequently applied this to study tPMET in cancer cells. We 46 
have developed a micromolar-level iron quantification method 47 
that is simple, with exceptionally low limits of detection, and 48 
that improves on current techniques to study tPMET on whole 49 
cells by allowing multiple redox state detection. This has led 50 
to new observations that cells from the same tissue behave 51 
differently in terms of how they use tPMET. This raises some 52 
interesting questions about the underlying biology and their 53 
function. This new application for electrochemistry has been 54 
fully validated with other analytical techniques which include 55 
biological toxicity assays and ICP-MS analysis of cellular iron 56 
content.  57 
Experimental section 58 
Materials. All reagents were purchased from Sigma-Aldrich, 59 
unless otherwise stated. 60 
Characterisation of FIC/FOC redox states for calibration. 61 
0.01 mM FIC and FOC (Acros Organics) solutions were both 62 
made in Hanks’ Balanced Salt Solution (HBSS). The two solu-63 
tions were mixed in a variety of combinations, from ratios 64 
10:0 to 0:10 FIC:FOC to give concentrations (µM) of each 65 
redox state respectively at: 0:10, 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 66 
7:3, 8:2, 9:1 and 0:10.  67 
A three electrode system comprising a 33 µm carbon fibre 68 
working microdisk electrode, a saturated calomel reference 69 
electrode, and a platinum wire counter electrode was used 70 
(ALS Co. Ltd, Japan). An Autolab PGStat302A potentiostat 71 
with low current detection module (ECD) (Metrohm Autolab, 72 
Utrecht, Netherlands) and NOVA 2.1 software was used in all 73 
experiments. 74 
Linear sweep voltammetry was performed with solutions con-75 
taining differing ratios of oxidized and reduced forms of iron 76 
(as above) and were carried out by scanning from 500 mV to -77 
150 mV, at a scan rate of 10 mV s-1. A current range of 100 78 
pA was used, with a low current module employed. A linear 79 
sweep voltammogram was recorded with the HBSS only act-80 
ing as a control to allow for baseline subtraction. Between 81 
each solution tested the microelectrode was polished for 4 82 
minutes using a PK-3 electrode polishing kit (ALS Co. Ltd, 83 
Japan). Pseudo-steady-state values were determined by as-84 
sessing a first derivative function of the voltammogram and 85 
cross referencing with the original curve to clarify that this 86 
was the voltage the pseudo-steady state was located. 87 
Stability of FIC in cell culture conditions. As outlined in 88 
Method S-1 of Supplementary Information. 89 
Investigation of electrode fouling. As outlined in Method S-90 
2 of the Supplementary Information. 91 
Growth study. The three cell lines analyzed in this study were 92 
Calu-3, H1299 and A549 cells. All cell lines were originally 93 
purchased from ATCC. All cells were grown in DMEM (Dul-94 
becco’s Modified Eagles Medium) containing high glucose 95 
supplemented with 10% FBS (fetal bovine serum), 100 U/ml 96 
penicillin, 100 µg/ml Streptomycin and 24 mM HEPES (N-(2-97 
Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid)) buffer. 98 
A549 cells were passage number 12 for the growth study, 99 
H1229 were passage number 13 and Calu-3 passage number 100 
41. A549 and H1299 cells were seeded at 0.10 x 106 cells/well 101 
and Calu-3 cells at 0.25 x 106 cells/well in 12 well plates. Via-102 
bility was tested each day for 10 days by first detaching cells 103 
from cell culture plates using 0.1 mL trypsin/EDTA, followed 104 
by addition of 10 µl cell suspension to 10 µl tryphan blue dye 105 
(TB). Dye exclusion analysis was then carried out using a 106 
Tecan microplate reader (Tecan Ltd, Weymouth, UK). A 107 
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growth curve was produced for each cell line, and a harvesting 1 
time selected that ensured all three cell lines were in an expo-2 
nential growth phase when used in subsequent experiments. 3 
Calu-3 cells were hence harvested after a 4 days growth, and 4 
A549 and H1299 cells following 3 days growth. All cells were 5 
harvested at a confluency of ~90%. 6 
Toxicity studies. The choice of buffer to use for preparing 7 
FIC, and its effect on cellular membrane integrity was evaluat-8 
ed using Lactate Dehydrogenase (LDH) assays (Tox7 Sigma-9 
Aldrich) in 96-well plate format. Cells were plated in densities 10 
corresponding to the above determination, at 8.4 x 104 11 
cells/well for A549 and H1299, and 21.0 x 104 cells/well for 12 
Calu-3 cells. A549 cells were passage 20-24, H1299 passage 13 
21-25 and Calu-3 passage 33-35.The three cell lines were in-14 
cubated with either 0.01M PBS (Phosphate Buffer Saline) or 15 
HBSS (Hanks’ Balanced Salt Solution) for 2 hours (37°C, 5% 16 
CO2). Each concentration was triplicated. Following the incu-17 
bation the LDH assay was performed using the manufacturer’s 18 
recommended method. This involved removing 75.0 µl/well of 19 
the cell-conditioned sample solutions and transferring to a 20 
fresh, clear 96-well plate. To these solutions 150.0 µl/well 21 
LDH reagent was added and the plate incubated at room tem-22 
perature in the dark for 25 minutes. Immediately after this the 23 
absorbance was measured at 492 nm, using a Tecan microplate 24 
reader. Plate absorbance was measured at 690 nm and sub-25 
tracted prior. Blanks were set up that consisted of the same 26 
HBSS or PBS solution used for cell-incubations, and LDH 27 
added as above, their values then subtracted from the appro-28 
priate measurement. Relative LDH release was calculated by 29 
setting the absorbance for the untreated cell control (DMEM) 30 
as 0%, and the positive control (0.2 % Triton X-100) was as-31 
sumed to result in total cell lysis and set at 100%. 32 
To determine the effect on metabolic rate of FIC solution in 33 
HBSS, we used the MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-34 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 35 
assay (CellTiter 96®, Promega) in 96-well plate format. Cells 36 
were seeded as described above for the LDH assay. The three 37 
cell lines were incubated with various concentrations (0.001, 38 
0.01, 0.1, 1, 2, 5, 10, 25, 50, 100 mM) of FIC in HBSS for 2 39 
hours (37°C, 5% CO2). Following incubation, cells were 40 
washed once with warm PBS and incubated with 20.0 µl MTS 41 
reagent in 100 µl DMEM (without antibiotics, 10% fetal bo-42 
vine serum (FBS)) per well for 2 hours at 37°C and 5% CO2. 43 
Absorbance readings and blank subtractions were taken as 44 
described for the LDH assay. Blank subtractions consisted of 45 
DMEM with 10% FBS added, without antibiotics. Relative 46 
metabolic activity was calculated by setting the absorbance for 47 
the untreated cell control (grown in DMEM) as 100%, and the 48 
positive control (0.2 % Triton X-100 solution) was assumed to 49 
result in total cell lysis and set at 0%. 50 
Electrochemistry on FIC incubated with cells for two 51 
hours. A549 cells were passage 17-19, H1299 passage 17-21 52 
and Calu-3 passage 28-29 for these experiments. The three cell 53 
lines were seeded at 6.3 x 105 cells/well for Calu-3 cells and 54 
2.5 x 105 cells/well for A549 and H1299 cells, in a 6 well plate 55 
and cultured in DMEM as outlined in the growth study sec-56 
tion. The growth medium was removed and each well washed 57 
three times with phosphate buffer saline (PBS). Solutions con-58 
taining only FIC (0.01 mM, 2 ml) was added to the wells and 59 
the plates incubated for 2 hours (37°C, 5% CO2). After the 60 
incubation 1ml of the supernatant was removed for electro-61 
chemical investigation. All parameters and procedures for 62 
electrochemical analysis were followed as outlined above. 63 
HBSS buffer was processed as the samples allow for normali-64 
sation of the electrochemical data by removing any electro-65 
chemical signals arising from the buffer. Bicinchoninic acid 66 
assay was carried out as described in Method S-3.    67 
pH testing of Hanks’ Balanced Salt Solution (HBSS) and 68 
0.01 mM Ferricyanide (FIC), before and after cell incuba-69 
tion. As outlined in Method S-5 of Supplementary Infor-70 
mation.                                  71 
 72 
Inductively coupled plasma mass spectrometry (ICP-MS) 73 
to quantitate cellular iron content. As outlined in Method 74 
S-6 of Supplementary Information. 75 
Results and Discussion 76 
It is paramount that we develop new systems to study trans- 77 
plasma electron transport (tPMET) and iron redox chemistry 78 
in biological systems. These two areas of study have been 79 
implicated within cancer biology3, and play an instrumental 80 
role within iron uptake mechanisms39,40. The challenge re-81 
search currently faces is that eukaryotic cells are notoriously 82 
temperamental and subject to extracellular and environmental 83 
change. Additionally, when looking at iron redox, FOC is de-84 
tected as opposed to FIC, where simultaneous detection could 85 
be advantageous. This detection of FOC production as op-86 
posed to FIC loss is attributable to the poor sensitivity of FIC 87 
due to a low extinction coefficient at the 420 nm detection 88 
wavelength7. In line with this task we have applied electro-89 
chemistry to produce an iron quantification system that does 90 
not induce cytotoxicity within our cell lines, whilst matching 91 
the current world-leader for lower detection limits and improv-92 
ing on this through the simultaneous quantification of two iron 93 
redox states. 94 
Calibration curve for iron quantification. Our chosen iron 95 
compound for analysis of extracellular reductive capability is 96 
FIC with a well-known one electron redox couple29,32,41.  FIC 97 
used in cellular based experiments to report on cellular iron 98 
reduction because FIC (Fe3+) can be reduced to FOC (Fe 2+) 99 
via cellular membrane bound reduction systems42. To assess 100 
the redox state of iron linear sweep voltammetry was em-101 
ployed32,33. The method works by assessing a shift in current 102 
values of the current/voltage curve generated within the volt-103 
ammogram, which indicates a change in the redox state of the 104 
iron compound. This is demonstrated in Figure S-2, and the 105 
corresponding calibration curve is displayed in Figure S-3. 106 
Cathodic currents (negative values) are indicative of FIC re-07 
duction and anodic current (positive current) values represent 108 
FOC oxidation. By identifying the position of both steady state 109 
anodic and cathodic currents we were therefore able to identi-110 
fy the quantity of FOC and FIC and therefore quantify iron 111 
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redox state changes in solution. To allow for this quantifica-1 
tion we carried out a characterization study with known con-2 
centrations of our redox states, thus producing a calibration 3 
curve (Figure S-3). The experiment was carried out at the 4 
same conditions as all subsequent electrochemical experiments 5 
(10 mV s-1, and at 37˚C). This also allowed for the determina-6 
tion of our lower limit of detection (LOD), calculated using 7 
the method outline by Armbruster et al43. The total iron con-8 
centration was kept constant at 0.01 mM whilst only the ratio 9 
of oxidized:reduced state was varied. Determination of steady-10 
state was by visual inspection of the first-derivative plot. The 11 
potential at which the line intersected the x axis whilst also 12 
maintaining a horizontal plateau was selected and the current 13 
noted for this point, these current values were then plotted 14 
against the known concentrations. The calibration plot gener-15 
ated had a R2 value of 0.987 for FOC and 0.995 for FIC, as 16 
shown in Figure S-3. The equations that are used in all later 17 
experiments for determination of iron concentration are also 18 
displayed in Figure S-3, where y is the current and x is the 19 
concentration of iron. 20 
The production of FOC by cells has been previously deter-21 
mined using colorimetric methods, most notably by Lawen et 22 
al7. We calculated our LOD43 at 0.44 µM for FOC and 0.97 23 
µM for FIC, indicating we are within the same order of magni-24 
tude for our system. When calculating our LOD for FOC de-25 
tection we took our 10:0 FIC:FOC sample (0 mM FOC) to be 26 
our blank and 9:1 FIC:FOC (0.001 mM FOC) to be our lowest 27 
concentration. We did this as we needed the steady- state an-28 
odic current value to use for the calculation. HBSS displays no 29 
faradaic current, and therefore it is impossible to test this as a 30 
blank. 31 
However, HBSS was tested under the same conditions and 32 
subtracted against all electrochemical analysis of iron, there-33 
fore normalizing our data to account for the non-faradaic elec-34 
trochemical contribution from the supporting electrolyte. The 35 
LOD calculated using this method provided us with a value in 36 
picoamperes, this was then converted into a concentration 37 
using our system sensitivities, derived from our equations 38 
obtained via Figure S-3. 39 
   40 
Figure 1. Growth study analysis of Calu-3, A549 and H1229 41 
cells. Calu-3 cells were seeded at 250,000 cell/well, and A549 and 42 
H1299 seeded at 100,000 cells/well. Growth profiles show clear 43 
lag, exponential and plateau phases. Harvesting times were cho-44 
sen to be within exponential growth phase. Viability was tested 45 
using tryphan blue. N=1, n=3.  46 
The system sensitivity for FOC was 4.67 pA/µM, and for FIC 47 
the sensitivity was 4.16 pA/µM. This method was applied for 48 
all subsequent iron quantification within additional electro-49 
chemical experiments. The same method as above was applied 50 
to calculate the LOD for FIC, except cathodic steady-state 51 
current values were used. The 95% prediction bands shown in 52 
Figure S-3 show that our data are very precise, with an aver-53 
age 95% prediction band value of +/- 3.71 picoamperes for the 54 
linear regression of FOC and +/- 2.20 picoamperes for FIC. 55 
This relates to all future values being expected to be within +/- 56 
0.89 µM of the regression line for FOC, and +/- 0.52 µM of 57 
the regression line for FIC. This method is also highly precise 58 
due to the base subtraction method employed, whereby a buff-59 
er-only sample is electrochemically analyzed and is subtracted 60 
from the FIC/FOC containing sample, thus removing all 61 
chemical noise contribution. If there is no species present 62 
within the FIC/FOC sample that passes higher faradaic current 63 
than the concentration of FIC/FOC used, then by subtracting 64 
the noise in the form of a non-FIC containing blank the ana-65 
lyzed current consist solely of FIC/FOC, and thus vastly re-66 
duces the chance of interfering electrochemical species and 67 
allowing for highly precise electrochemical analysis. 68 
Growth parameters and toxicity. To begin our cell work we 69 
selected three oncogenic cell lines that would allow us to de-70 
termine whether there was a link between growth rate and 71 
their ability to reduce extracellular iron. The chosen cell lines 72 
all originate from lung epithelium, and are well characterized 73 
within the literature44,45,46. It was important to assess the cells 74 
growth patterns to ensure cells were harvested within the same 75 
growth phase, and to elucidate the cell viability when grown in 76 
ideal conditions (FBS-supplemented cell culture medium). 77 
This was important because if not within the same growth 78 
phase the cells would not be directly comparable, and if the 79 
cells viability was compromised we would not be analyzing a 80 
repeatable system. Therefore we performed a growth study 81 
(Figure 1). Assessment of growth rate was done using a Tecan 82 
plate reader with cell counting and viability functions and 83 
needed optimizing which is discussed in SI Method S-4. As 84 
can be seen from Figure 1, our growth curves show a defined 85 
lag, exponential and plateau phases. Harvesting time was cho-86 
sen at three days for H1299 cells and A549 cells, and four 87 
days for Calu-3 cells. These times were chosen as all cell lines 88 
would then be in the same phase of growth, but also the cell 89 
number for Calu-3 cells would be more comparable to A549 90 
and H1299 cells after four days. We needed to determine the 91 
doubling time of the cells to have a quantifiable measure of 92 
the proliferative rate of the cells (also tell you about the cell 93 
cycle is effected by toxicity). Doubling time was determined 94 
by taking the same portion of the exponential phase, 200,000 95 
to 400,000 cells/ml, and calculating the time taken in days to 96 
achieve this doubling. H1299 cells had the quickest doubling 97 
time at 0.816 days, followed by A549 cells at 1.123 days, and 98 
finally Calu-3 cells at 3.804 days. The doubling times 99 
achieved mimic the literature for A549 and H1299 cells47, and 100 
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to the best of our knowledge a value for Calu-3 doubling time 1 could not be found. The range of cell  2 
 3 
 4 
Figure 2. Examples of linear sweep voltammogram obtained for each cell line. Cell were exposed to solutions of 0.01 potassium ferricya-5 
nide for 2 hours prior to supernatants being taken for electrochemical analysis. Calu-3 (left), H1299 (middle), A549 (right). Hank’s Bal-6 
anced Salt Solution (HBSS) buffer with 0.01 mM potassium ferricyanide in the absence (blue) and presence (red) of cells. Scan rate, 10 7 
mV.s-1. N=3, n=3. 8 
types we have chosen therefore allows us to compare A549 9 
and H1299 cells which have a similar doubling rate of 0.816 10 
and 1.123, with the less proliferative cell line Calu-3. It was 11 
important that we checked cell viability to ensure we were 12 
not providing a stressful environment to the cells, which in 13 
turn can cause changes in metabolism48. Cell viability in 14 
ideal conditions, as demonstrated on the right-hand axis of 15 
Figure 1, demonstrates the cell lines are in a favorable envi-16 
ronment prior to treatment with iron.   17 
Having characterized the growth system for this experiment 18 
the choice of buffer to be used as our supporting electrolyte, 19 
as well as any cytotoxicity in response to FIC/FOC, was 20 
analyzed. The employment of a highly sensitive electro-21 
chemical system meant the presence of electrochemically 22 
active species in the supporting electrolyte had to be consid-23 
ered, as they may have contributed to the signal that was 24 
collected. Additionally, the supporting electrolyte had to be 25 
the correct osmolality to ensure cytolysis did not occur, and 26 
that the cells did not undergo undue stress. Two commonly 27 
used salt-based cell culture buffers were tested – PBS and 28 
HBSS. The main differences between these buffers are their 29 
salt components, in addition to the presence of magnesium 30 
ions, calcium ions, and D-glucose within HBSS. 31 
PBS was chosen as it is a more minimal salt buffer in com-32 
parison to HBSS, thus there would be little scope for it to 33 
electrochemically interfere with our analytical signal. HBSS 34 
was chosen as, although it has more components, the added 35 
magnesium and calcium are important for cell adhesion, and 36 
the D-glucose present provided a substitute for serum ensur-37 
ing the cells had an energy source. An LDH assay and the 38 
MTS assay was performed with cells exposed to the differ-39 
ent electrolyte. The LDH assay measures cell membrane 40 
integrity and so gave us an indication of whether the mem-41 
brane was perturbed, which is indicative of cell death. Iron 42 
interferes with the LDH assay so only buffer was assessed 43 
here. The MTS assay measures metabolic activity, and 44 
therefore is indicative of sub-lethal toxicity. Iron cytotoxici-45 
ty was assayed in this way, after a suitable buffer was cho-46 
sen. This allowed us to indirectly assess irons effect upon 47 
membrane integrity as the MTS assay was carried out with 48 
iron in solution with the preferred buffer.  49 
LDH assay data is shown in Figure S-6A. It demonstrates 50 
that HBSS is the preferred buffer, relative to PBS, although 51 
the LDH release is relatively low in both cases. The MTS 52 
assay data on toxicity of FIC is displayed in Figure S-6B, 53 
and demonstrates FIC in HBSS does not become cytotoxic 54 
over two hours until ~10 mM concentration. This meant that 55 
our chosen concentration of 0.01 mM was suitable. The 56 
LDH and MTS assays data are discussed in further detail in 57 
the Figure S-6 section of the Supplementary Information. 58 
Electrochemical analysis of cell-incubated samples. The 59 
cell culture conditions and electrochemical assay that we 60 
developed and characterised were used to assess the cells 61 
ability to reduce FIC to FOC. Solutions of FIC were first 62 
analyzed by generating a linear sweep voltammogram 63 
(LSV) of FIC solutions only (Figure 2). The solutions of 64 
FIC were incubated with the cells for two hours at 37°C and 65 
5% CO2, before LSVs were generated of the supernatants of 66 
the incubated FIC samples (Figure 2). FIC only samples 67 
(Figure 2, blue) produced only cathodic (reductive) cur-68 
rents, with the anodic steady state plateauing at 0 pA, thus 69 
indicating the absence of FOC. Upon incubation with each 70 
cell line an upward shift in the current measurements was 71 
observed (Figure 2, red), indicating a shift of redox states 72 
to both FOC and FIC. When incubated with the cells we can 73 
deduce that FIC is reduced to FOC, and thus when we scan 74 
across our potential range both oxidation and reduction oc-75 
curs as both redox states undergo electron transfer. It can 76 
clearly be observed visually that Calu-3 cells (left) reduce 77 
less iron than H1299 (middle), and H1299 cells in turn re-78 
duce less than A549 cells (right). It is also apparent that 79 
there is a slight change in the shape and half-wave potentials 80 
of the voltammograms. We suggest that this may be due to 81 
minor changes in the pH of the solutions and potential pH 82 
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discrepancies between HBSS and FIC after cell incubation. 1 
The pH data is presented in Figure S-7 and discussed there-2 
in.  It is well established that pH can affect the half-wave 3 
potential of such electrochemical reactions as we have pre-4 
viously reported 32. 5 
 6 
 7 
8 
 Figure 3. Electrochemical analysis of cellular reduced 0.01 9 
mM potassium ferricyanide in Hank’s Balanced Salt Solution 10 
(HBSS) buffer. (A) Concentration of potassium ferricyanide 11 
produced, normalized by protein quantification. Statistical 12 
analysis was carried out using a one-way ANOVA with Tukey's 13 
multiple comparisons test at P = 0.0453 for Calu-3 vs H1299, 14 
and P = 0.0001 for all other comparisons. N=3, n=3. (B) Total 15 
iron concentration before and after cell incubation. Pre cell 16 
incubation samples are significant to P = 0.0001 for all cell 17 
types, compared to post cell incubation samples. This was de-18 
termined by two-way ANOVA with Sidak's multiple compari-19 
sons test. SEM error bars shown N=3, n=3. Cell appear to be 20 
viable in optimal conditions, and undergo stress when trans-21 
ferred into an alternative medium. 22 
Quantification of iron reduction and comparison be-23 
tween cell types. Quantification of the iron reduction was 24 
calculated using steady states from both FIC only (Figure 2, 25 
blue) and FIC/FOC after cell incubation (Figure 2, red) 26 
samples from Figure 2. Determination of steady states and 27 
subsequent iron quantification calculations employed the 28 
same method outlined for our calibration plot. The steady 29 
states for these calculations were determined using the data 30 
presented in Figure 2 (blue and red), once again using the 31 
method outlined for our calibration plot. Figure 3A shows 32 
the amount of FOC produced by the cell lines, which has 33 
been normalised for the amount of protein present in each 34 
well plate, thus allowing direct comparison between cell 35 
lines. The amount of FOC produced in nM per ug of protein 36 
was 1.25, 2.18 and 5.19 for Calu-3, H1299 and A549 cells 37 
respectively. The significance of these results was deter-38 
mined using an one-way ANOVA with Tukey’s multiple 39 
comparison test, which showed significance between Calu-3 40 
and H1299 reduction of p =  0.0084 and A549 to all other 41 
cell lines of p = 0.0001. The robustness of our system in 42 
analysing this reduction is also demonstrated with our low 43 
coefficients of variation (%CVs) internally between cell 44 
samples, at 15.80, 7.41 and 6.58% for Calu-3, H1299 and 45 
A549 cells respectively. The importance of these results is 46 
indicated when taking data from our doubling times data, 47 
mitochondrial metabolic rates, and Figure 3A. We can ob-48 
serve that there is no link between the doubling time, and 49 
therefore cell cycle differences between the cells, and the 50 
amount of FOC produced. In addition, there is no link be-51 
tween mitochondrial metabolic rate and FOC production. 52 
Although FOC production is increased when comparing our 53 
least proliferative cell line (Calu-3) to our other two (A549 54 
and H1299), we would expect H1299 to have a marginally 55 
higher reductive power in relation to A549 cells, or at least 56 
to have a similar reductive power when comparing to prolif-57 
eration, but A549 cells reduce 3.01 nM/ug of protein more 58 
FIC than H1299 cells. Our rationale behind a possible link 59 
with mitochondrial metabolic rate and therate of tPMET 60 
activity was that higher metabolic rate cells would have a 61 
faster turnover of reversible redox couples, and as such have 62 
more capability to reduce iron via tPMET. This was not the 63 
case, where Calu-3 cells with the highest metabolic rate 64 
reduce the least iron (and therefore have the lowest tPMET 65 
activity) whilst H1299 with the lowest mitochondrial meta-66 
bolic rate have a higher tPMET activity. This highlights how 67 
important it is to study tPMET systems in biology, as there 68 
is evidently much to be understood about how the underly-69 
ing biology and biochemistry of the cells affects these 70 
transport mechanisms. It has been suggested18 that trans 71 
plasma membrane electron transport (tPMET) can occur via 72 
two mechanisms: either through membrane-bound oxidore-73 
ductase activity, or through a shuttle-based system exporting 74 
reducing equivalents. We hypothesise that a mixture of the-75 
se systems is in play here, and in subsequent research will 76 
hope to elucidate the exact mechanisms of the reduction we 77 
have detected here, in addition linking the biological causes 78 
of these cell lines have differing reductive capabilities. 79 
Figure 3B shows the quantification of total iron concentra-80 
tion. We observe a reduction in total iron concentration 81 
across all cell lines after incubation with the cells. This is 82 
significant at p = 0.001 for all cell lines, as assessed by two-83 
way ANOVA with Sidak’s multiple comparison test. It was 84 
important to demonstrate that FIC was not entering the cell 85 
as the goal of these investigations was to study tPMET and 86 
not iron reduction via internal electron transfer systems in-87 
side of the cell. A landmark paper by Keilin et al 49 showed 88 
that FIC does not cross the plasma membrane. However we 89 
wished to confirm this and therefore performed ICP-MS to 90 
quantitate cellular iron.  With the premise being if FIC was 91 
entering the cell we would see an increase in cellular iron 92 
content when cells were incubated with solutions of FIC 93 
versus in its absence.   94 
Our data represented in Figure S-8 corroborates with Keilin 95 
et al, and proves for our system that the iron content of the 96 
cell is not affected by incubation with FIC. This in turn 97 
means that neither FIC nor FOC are entering into, or adher-98 
ing onto the surface of the cells. Iron content values per cell 99 
for HBSS incubated samples were 0.14, 0.12 and 0.13 pg for 100 
Calu-3, H1299 and A549 cells respectively, and 0.15, 0.12 101 
and 0.10 pg respectively for FIC incubated samples. Two-102 
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way ANOVA with Sidak’s multiple comparison test showed 1 
no significant different with between HBSS or FIC incubat-2 
ed samples, and no significant difference between cell lines. 3 
The iron content of the cells appears to be in line with the 4 
literature when normalised for cell number, Mathiasen et al 5 
50 present iron levels for mesenchymal stem cells of 0.48 6 
pg/cell, Mojic et al 51 present values of 0.3 pg/cell for pros-7 
tate cancer cell lines LNCaP and PC3, and although an un-8 
treated sample is not shown, Kumar et al 52 present A549 9 
cells as having ~2.8 pg of iron/cell when incubated with 10 
superparamagnetic iron oxide nanoparticles, indicating that 11 
pictograms are in line with expected values. Another im-12 
portant point to note is that our stability data indicates this 13 
reduction in total iron concentration cannot be from instabil-14 
ity and subsequent deterioration of the redox couple under 15 
variable conditions. In addition to this we tested whether the 16 
electrode would be fouled by using cell-incubated material 17 
to ensure that this was not the cause of total iron reduction 18 
(SI Figure S-4). We performed the analysis on cells in PBS 19 
as the membrane integrity for PBS incubated cells was low-20 
er (LDH assay, SI Figure S6) and thus there would be more 21 
potential for electrode fouling by released components. We 22 
found there to be no evidence of electrode fouling, as 23 
demonstrated by paired t-test of a 0.01 mM FIC solution 24 
electrochemically analysed before and after the microelec-25 
trode has been used with a cell-incubated sample, at p = 26 
0.1406.  In light of our findings, we would therefore tenta-27 
tively suggest that FIC and/or FOC is interacting electrostat-28 
ically with a cell-effluxed molecule, thus resulting in a ‘loss’ 29 
of FIC and/or FOC from the supernatant. 30 
Interestingly, this detection of a change in total iron concen-31 
tration highlights one of the major advantages of using an 32 
electrochemical method to quantitate FOC production. Im-33 
proving on the colorimetric methods of Lane et al, and 34 
Avron and Shavrit, our system allows for the quantification 35 
of both the oxidised and reduced states, as opposed to only 36 
the reduced state. This advancement is already having high-37 
ly relevant and impactful ramifications, as it has flagged 38 
interesting findings in our system that would not have been 39 
detected if we had employed the colorimetric method. Com-40 
bined with matching Lane et al as the current world-leader 41 
in detection limit for FOC, this provides a very robust sys-42 
tem to analyze cellular-induced FOC production. Addition-43 
ally, another interesting advantage is the lack of requirement 44 
for addition of acid to the sample. 45 
Conclusion  46 
 47 
Here we have demonstrated a novel application for analyti-48 
cal electrochemistry by quantitating cellular iron reduction 49 
in oncogenic eukaryotes, and by doing so have created a 50 
highly sensitive system that can be used to detect quantities 51 
of both FIC and FOC simultaneously. The technique con-52 
tends with the current world leaders for detection limits of 53 
FOC, and provides a detection limit for FIC also that is 54 
within the same order of magnitude. We have used linear 55 
sweep voltammetry to assess the iron reduction capability of 56 
three lung cancer cell lines, and link this to the proliferative 57 
rates and mitochondrial metabolic rates of the cell lines in 58 
question. Furthermore, the reproducibility of our cell work 59 
with relatively low variability in the spread of the data for a 60 
biological system, once again demonstrating the robustness 61 
of this model for investigation. We have identified differ-62 
ences in iron reduction capability, showing that a higher 63 
proliferative rate or metabolic rate does not necessarily re-64 
sult in a higher reductive capability, highlighting a deficien-65 
cy in the biological knowledge of these systems. This work 66 
will be highly relevant and have high impact across a di-67 
verse set of fields, driving forward multidisciplinary re-68 
search especially in relation to tPMET systems53 and their 69 
presence in oncogenic cell lines3. It also provides an insight 70 
into the biology of our studied cell lines, which are com-71 
monly used as lung epithelium models. Moreover the devel-72 
oped assay offers a generic technique to study tPMET in any 73 
cells. 74 
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